Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

Seghieri, M; Christensen, AS; Andersen, A; Solini, A; Knop, FK; Vilsboll, T

Vilsboll, T (reprint author), Univ Copenhagen, Gentofte Hosp, Steno Diabet Ctr Copenhagen, Clin Metab Physiol, Copenhagen, Denmark.; Vilsboll, T (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark.

FRONTIERS IN ENDOCRINOLOGY, 2018; 9 ():

Abstract

Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic ......

Full Text Link